12:00 AM
 | 
Oct 12, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Indantadol: Pilot trial started

Vernalis began a U.K. pilot trial to evaluate oral V3381 in up to 20 patients. The product is also in Phase II...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >